MERONI, MARINA
 Distribuzione geografica
Continente #
AS - Asia 1.455
NA - Nord America 1.063
EU - Europa 599
SA - Sud America 226
Continente sconosciuto - Info sul continente non disponibili 64
AF - Africa 28
Totale 3.435
Nazione #
US - Stati Uniti d'America 1.021
SG - Singapore 451
CN - Cina 292
VN - Vietnam 257
IT - Italia 231
HK - Hong Kong 158
BR - Brasile 153
RU - Federazione Russa 152
BD - Bangladesh 56
KR - Corea 53
DE - Germania 48
IN - India 47
ID - Indonesia 30
NL - Olanda 28
GB - Regno Unito 25
FR - Francia 24
AR - Argentina 23
CA - Canada 21
IQ - Iraq 21
CO - Colombia 17
FI - Finlandia 15
EC - Ecuador 13
AT - Austria 12
ES - Italia 12
PH - Filippine 12
SA - Arabia Saudita 11
MX - Messico 10
SE - Svezia 10
TR - Turchia 10
ZA - Sudafrica 10
JP - Giappone 9
PK - Pakistan 8
PL - Polonia 8
UA - Ucraina 8
IE - Irlanda 6
JO - Giordania 6
MA - Marocco 6
VE - Venezuela 6
CH - Svizzera 5
MY - Malesia 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
CL - Cile 3
PE - Perù 3
PY - Paraguay 3
RO - Romania 3
TH - Thailandia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
BO - Bolivia 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
NI - Nicaragua 2
PT - Portogallo 2
TN - Tunisia 2
AF - Afghanistan, Repubblica islamica di 1
BF - Burkina Faso 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HT - Haiti 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
PA - Panama 1
PS - Palestinian Territory 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 3.372
Città #
Singapore 292
San Jose 202
Hong Kong 157
Hefei 103
Hanoi 94
Milan 91
Ashburn 82
Ho Chi Minh City 70
Seoul 53
Beijing 49
Council Bluffs 49
Santa Clara 45
Chicago 38
Los Angeles 32
Burlingame 29
Rome 25
Moscow 23
Dallas 20
Jakarta 20
New York 20
Munich 19
Buffalo 17
The Dalles 17
Shanghai 16
São Paulo 16
Hyderabad 14
Lauterbourg 13
Haiphong 12
Orem 12
Baghdad 10
Chennai 10
Da Nang 9
San Francisco 9
Amsterdam 8
Quito 8
Tokyo 8
Boardman 7
Chandler 7
Guangzhou 7
Helsinki 7
Washington 7
Amman 6
Boston 6
Dhaka 6
Dublin 6
Figino 6
Frankfurt am Main 6
Kochi 6
Newark 6
Nuremberg 6
Poplar 6
Warsaw 6
Bari 5
Biên Hòa 5
Brooklyn 5
Istanbul 5
Montreal 5
Mumbai 5
Philadelphia 5
Phoenix 5
Redwood City 5
Reggio Emilia 5
Rio de Janeiro 5
Salt Lake City 5
Turin 5
Vienna 5
Arezzo 4
Atlanta 4
Barcelona 4
Bogotá 4
Brasília 4
Charlotte 4
Dammam 4
Denver 4
Jacksonville 4
Kent 4
London 4
Mountain View 4
Naples 4
Porto Alegre 4
Snellville 4
Tashkent 4
Thái Nguyên 4
Baku 3
Belo Horizonte 3
Bitonto 3
Bắc Ninh 3
Can Tho 3
Caxias do Sul 3
Columbus 3
Ha Long 3
Hamburg 3
Jeddah 3
Johannesburg 3
Kuala Lumpur 3
Lappeenranta 3
Las Vegas 3
Lima 3
Lincoln 3
Manaus 3
Totale 1.982
Nome #
Induction of adipocytic differentiation in myxoid liposarcoma: new approaches to improve the effectiveness of the available therapies 415
MSIpixel: a fully automated pipeline for compound annotation and quantitation in mass spectrometry imaging experiments 242
Distribution of pamiparib, a novel inhibitor of poly(ADP-ribose)-polymerase (PARP), in tumor tissue analyzed by multimodal imaging 198
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models 185
Mechanism of efficacy of trabectedin against myxoid liposarcoma entails detachment of the FUS-DDIT3 transcription factor from its DNA binding sites 175
Establishment and characterization of a new panel of uterine leiomyosarcoma patient-derived xenograft models 166
Abstract 7199: The retinoid X receptor (RXR) agonist IRX4204 potentiates the efficacy of trabectedin and pioglitazone in myxoid liposarcoma preclinical models 163
Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy 162
Pharmacokinetics of the combination of trabectedin and pioglitazone in myxoid liposarcoma patient-derived xenograft models 158
Pharmacokinetic evaluation of trabectedin and pioglitazone combination in myxoid liposarcoma patient-derived xenografts. 155
The combination of the PPARγ agonist pioglitazone and the RXR agonist IRX4204 induces adipocytic differentiation in myxoid liposarcoma 152
Induction of adipocytic differentiation in myxoid liposarcoma: new approaches to improve the effectiveness of the available therapies 151
Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma 147
Betulinic acid and its spray dried microparticle formulation: In vitro PDT effect against ovarian carcinoma cell line and in vivo plasma and tumor disposition 146
Quantitative measurement of pioglitazone in neoplastic and normal tissues by AP-MALDI mass spectrometry imaging 145
Enhancing Pt(IV) Complexes' Anticancer Activity upon Encapsulation in Stimuli‐Responsive Nanocages 141
Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells 140
The combination of the PPARγ agonist pioglitazone and the RXR agonist IRX4204 induces adipocytic differentiation in myxoid liposarcoma. 134
Corrigendum to “Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma” [Genomics Volume 113, Issue 5, September 2021, Pages 3439–3448] (Genomics (2021) 113(5) (3439–3448), (S0888754321003062), (10.1016/j.ygeno.2021.07.028)) 131
Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice 129
Totale 3.435
Categoria #
all - tutte 11.128
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.128


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202317 1 1 1 3 2 4 0 3 2 0 0 0
2023/2024123 0 1 0 7 4 5 33 12 12 2 6 41
2024/20251.084 38 94 54 33 46 48 50 55 120 125 105 316
2025/20261.895 213 174 174 230 215 65 183 91 181 119 82 168
2026/2027316 103 98 115 0 0 0 0 0 0 0 0 0
Totale 3.435